117 related articles for article (PubMed ID: 20859224)
1. Oral tuberculosis in a patient with rheumatoid arthritis after long treatment with methotrexate and adalimumab.
Barouta G; Karapetsa M; Kostopoulou E; Alexiou I; Koukoulis G; Sakkas LI
J Clin Rheumatol; 2010 Oct; 16(7):330-1. PubMed ID: 20859224
[TBL] [Abstract][Full Text] [Related]
2. Oral tuberculosis associated with a treatment with anti-rheumatic drugs.
Kolokotronis A; Avramidou E; Zaraboukas T; Mandraveli K; Alexiou S; Antoniades D
J Oral Pathol Med; 2006 Feb; 35(2):123-5. PubMed ID: 16430744
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab.
Assante LR; Barra E; Bocchino M; Zuccarini G; Ferrara G; Sanduzzi A
Infez Med; 2014 Jun; 22(2):144-8. PubMed ID: 24955803
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tuberculosis secondary to adalimumab.
Pednekar M; Chandra AB; Chandra PA
Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
[TBL] [Abstract][Full Text] [Related]
6. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
[TBL] [Abstract][Full Text] [Related]
7. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
8. [Adalimumab].
Goto D; Sumida T
Nihon Rinsho; 2002 Dec; 60(12):2384-9. PubMed ID: 12510366
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment.
Bassetti S; Wasmer S; Hasler P; Vogt T; Nogarth D; Frei R; Widmer AF
J Rheumatol; 2005 Nov; 32(11):2125-9. PubMed ID: 16265689
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
14. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
Lovell DJ; Ruperto N; Goodman S; Reiff A; Jung L; Jarosova K; Nemcova D; Mouy R; Sandborg C; Bohnsack J; Elewaut D; Foeldvari I; Gerloni V; Rovensky J; Minden K; Vehe RK; Weiner LW; Horneff G; Huppertz HI; Olson NY; Medich JR; Carcereri-De-Prati R; McIlraith MJ; Giannini EH; Martini A; ;
N Engl J Med; 2008 Aug; 359(8):810-20. PubMed ID: 18716298
[TBL] [Abstract][Full Text] [Related]
16. Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.
Gremese E; Carletto A; Padovan M; Atzeni F; Raffeiner B; Giardina AR; Favalli EG; Erre GL; Gorla R; Galeazzi M; Foti R; Cantini F; Salvarani C; Olivieri I; Lapadula G; Ferraccioli G;
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):94-100. PubMed ID: 22730143
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Carmona L; Gómez-Reino JJ; Rodríguez-Valverde V; Montero D; Pascual-Gómez E; Mola EM; Carreño L; Figueroa M;
Arthritis Rheum; 2005 Jun; 52(6):1766-72. PubMed ID: 15934089
[TBL] [Abstract][Full Text] [Related]
18. Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.
Iannone F; Gremese E; Atzeni F; Biasi D; Botsios C; Cipriani P; Ferri C; Foschi V; Galeazzi M; Gerli R; Giardina A; Marchesoni A; Salaffi F; Ziglioli T; Lapadula G;
J Rheumatol; 2012 Jun; 39(6):1179-84. PubMed ID: 22467933
[TBL] [Abstract][Full Text] [Related]
19. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
